20190-1-8 5.Yip TC,Wong VW.Chan HL,ete:Tenofovir is associated with lower risk of hepatocelluar carcinoma than entecavir in patients with chronic HBV infection in China.Gastroenterology 2020:158:215-225. 2019;0:1-8 5. Yip TC, Wong VW, Chan HL, etc: Tenofovir is associated with lower risk of hepatocelluar carcinoma than entecavir in patients with chronic HBV infection in China. Gastroenterology 2020;158:215-225